Current Roles

Employees:
9
Revenue:
$1.4M
About
GammaDelta Therapeutics has been founded on pioneering research into gamma delta (??) T cells led by Professor Adrian Hayday and Dr Oliver Nussbaumer at King’s College London and the Francis Crick Institute and funded in part by Cancer Research UK. The Company has a team of experienced management, strong academic pedigree and excellent potential for clinical development.
GammaDelta Therapeutics Address

null, null
UK
GammaDelta Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.